JG

Jesse Green

Director at Sana Biotechnology

Jesse Green has a diverse work experience in the field of biotechnology and scientific research. They currently hold the position of Principal Scientist at Sana Biotechnology, Inc., where they have been working since 2022. Prior to this, they worked as a Senior Scientist at the same company from 2021 to 2022.

Before joining Sana Biotechnology, Jesse worked at Regeneron Pharmaceuticals, Inc. as a Staff Scientist from 2018 to 2021.

Their previous experience also includes a role as a Research Fellow at Memorial Sloan Kettering Cancer Center from 2011 to 2018. During this time, Jesse focused on investigating the role of Treg cells and effector T cells in lung tumors, including profiling the dynamics of T cell populations and screening tumor-resident Treg cells for expressed genes with novel functions.

Jesse began their career as a Ph.D. Student at the University of California, San Francisco from 2006 to 2011, where they studied the spatial organization and growth control of germinal centers, with a particular focus on S1P receptor S1PR2 and its role in regulating germinal center B cells. They also contributed to a collaboration identifying alterations in the Galpha13 signaling pathway in human lymphoma.

Prior to their Ph.D. studies, Jesse gained research experience as an Undergraduate Researcher at the University of Washington from 2004 to 2005.

Overall, Jesse Green's work experience spans a variety of roles in the biotechnology and scientific research sectors, highlighting their expertise in cellular and molecular biology and their contributions to cancer research.

Jesse Green obtained a Bachelor of Science degree in Molecular Biology from the University of Washington in 2005. In 2011, Jesse completed a Doctor of Philosophy degree in Immunology from the University of California, San Francisco.

Location

Cambridge, United States

Links

Previous companies


Org chart

This person is not in the org chart


Teams


Offices

This person is not in any offices


Sana Biotechnology

2 followers

Sana Biotechnology is focused on utilizing engineered cells as medicines for patients. The ability to modify genes and use cells as medicines will be one of the most important advances in healthcare over the next several decades. Sana is building differentiated capabilities across the spectrum of cell and gene therapy.


Industries

Employees

201-500

Links